Johnson & Johnson’s Sales Slide 11% During the Pandemic

Declines in medical devices and beauty products led the way

johnson & johnson logo on a phone screen
J&J's pharmaceutical unit proved resilient even during the pandemic. Getty Images

Johnson & Johnson’s worldwide year-over-year sales declined 10.8% in the second quarter of 2020, as fewer consumers had elective surgery or opted to buy beauty products during the pandemic.

@hiebertpaul paul.hiebert@adweek.com Paul Hiebert is a CPG reporter at Adweek, where he focuses on data-driven stories that help illustrate changes in consumer behavior and sentiment.
{"channel":"elasticpress","title":"Recommended","post_types":["post","page"],"lineup_id":"54851","since_qty":30,"since_time":"d","until_qty":0,"until_time":"m","q":"","num_posts":0,"vertical":"brand-marketing"}